<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02505828</url>
  </required_header>
  <id_info>
    <org_study_id>93612</org_study_id>
    <secondary_id>2014-A01561-46</secondary_id>
    <nct_id>NCT02505828</nct_id>
  </id_info>
  <brief_title>ARTEMIS Synovial Markers in Arthritis Childhood</brief_title>
  <acronym>ARTEMIS</acronym>
  <official_title>ARTEMIS Synovial Markers in Arthritis Childhood</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to find markers that could differentiate infectious and inflammatory
      arthritis. The investigators want to find markers by differential analysis by compare
      synovial fluids of septic and inflammatory arthritis. The investigators will use for this
      analysis, proteomics, cytokine dosage and monocyte typing by flow cytometry analysis. The
      investigators will use one marker or a score with biological and clinical data to
      discriminate arthritis of infectious and inflammatory etiology.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Qualitative analysis of new biological markers (proteic, cytokine or cellular) that discriminate inflammatory and infectious arthritis.</measure>
    <time_frame>1 day</time_frame>
    <description>Identify blood sampling biomarkers of Arthritis childhood</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Septic Arthritis</condition>
  <condition>Juvenile Idiopathic Arthritis</condition>
  <arm_group>
    <arm_group_label>Septic arthritis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>with bacteriological identification</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Juvenile idiopathic arthritis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>beyond the ILAR (International League of Associations for Rheumatology) definition</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Articular punction, salivary samples, blood sample</intervention_name>
    <arm_group_label>Septic arthritis</arm_group_label>
    <arm_group_label>Juvenile idiopathic arthritis</arm_group_label>
    <other_name>Proteomic analysis</other_name>
    <other_name>Cytokine dosage</other_name>
    <other_name>Monocyte</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Septic arthritis with bacteriological identification

          -  Juvenile idiopathic arthritis beyond the ILAR definition

          -  Having acute arthritis requiring an articular draining

          -  Child benefiting from a national insurance scheme

          -  Collection of the consent of the parents or the legal representative

        Exclusion Criteria:

          -  Contraindication in an articular draining: platelet 50 000 / mm3, Rate of prothrombins
             lower than 70 %, activated partial thromboplastin times (APTT)&gt; 1,5

          -  Treatment by biotherapy, corticoids or other immuno suppressor in the month preceding
             the articular draining.

          -  Treatment by antibiotic begun more than 24 hours before the draining.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric EJ JEZIORSKI, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montpellier University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>HÃ´pital Arnaud de Villeneuve</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 22, 2015</study_first_submitted>
  <study_first_submitted_qc>July 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2015</study_first_posted>
  <last_update_submitted>July 20, 2015</last_update_submitted>
  <last_update_submitted_qc>July 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Arthritis</keyword>
  <keyword>septic</keyword>
  <keyword>Juvenile idiopathic arthritis</keyword>
  <keyword>diagnosis</keyword>
  <keyword>proteomic</keyword>
  <keyword>cytokine</keyword>
  <keyword>monocytes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Juvenile</mesh_term>
    <mesh_term>Arthritis, Infectious</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

